Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Bullboard - Stock Discussion Forum Therma Bright Inc V.THRM

Alternate Symbol(s):  TBRIF

Therma Bright Inc. is a Canada-based company, which is a developer and partner in a range of diagnostic and medical device technologies. It focuses on providing consumers and medical professionals with solutions that address medical and healthcare challenges. It is involved in developing, acquiring, manufacturing, and marketing proprietary healthcare and medical devices for the consumer and... see more

TSXV:THRM - Post Discussion

Therma Bright Inc > ANOTHER COVID-19 HOME TEST.. available
View:
Post by Mole101 on Jan 29, 2021 9:02pm

ANOTHER COVID-19 HOME TEST.. available

The Ellume COVID-19 Home Test is an over-the-counter, rapid self-test which detects SARS-CoV-2 antigen. The test is suitable for ages 2+ years and will be available for non-prescription use in the U.S*. It enables individuals, with and without symptoms, to test for COVID-19 infection in 15 minutes, anywhere.

Utilizing the dedicated App, users follow step-by-step instructions to perform the test including a self-collected mid-turbinate swab. The sample is analyzed and results are automatically transmitted to the user’s smartphone via Bluetooth®. Results can be shared with healthcare professionals to enable optimal therapy.

Through a secure, HIPAA compliant cloud connection, the Ellume COVID-19 Home Test provides real-time reporting of results and critical patient data to health authorities, employers and educators, for efficient COVID-19 mapping.

In U.S. – For use under Emergency Use Authorization (EUA) The Ellume COVID-19 Home Test correctly identified 96% of positive samples and 100% of negative samples in individuals with symptoms. In people without symptoms, the test correctly identified 91% of positive samples and 96% of negative samples.

Comment by Mole101 on Jan 29, 2021 9:37pm
Research and Development $$.this will be a major issue at THRM. just so you know that this isn't a strait forward process...  Manufacturing Scale-Up Ellume has been able to fast-track the development of its range of COVID-19 diagnostic tests with the support of a$30 million WP-2 grant from the U.S. National Institutes of Health (NIH)’s Rapid Acceleration of Diagnostics (RADx ...more  
Comment by moonball32 on Jan 29, 2021 11:36pm
This was brought up and discussed over a week ago on this forum, it's old news. Re-read the posts regarding this company you will find some very insightful comments, NOT fearmongering, factual and logical discussions.
Comment by optex1972 on Jan 30, 2021 1:12am
The hottest tech is blowfish right now and MEDV is in that. And they make money. I got some bets here but going more into revenue generators versus speculation stocks as of late. 
Comment by Greenrolls8 on Jan 30, 2021 9:00am
This post has been removed in accordance with Community Policy
Comment by Greenrolls8 on Jan 30, 2021 8:55am
This post has been removed in accordance with Community Policy
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities